Nicofuranose: Difference between revisions
m (Protected "Nicofuranose": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| IUPAC_name = [(2R,3S,4R,5R)-2-hydroxy-4-(pyridine-3-carbonyloxy)-2,5-bis(pyridine-3-carbonyloxymethyl)oxolan-3-yl] pyridine-3-carboxylate | | IUPAC_name = [(2R,3S,4R,5R)-2-hydroxy-4-(pyridine-3-carbonyloxy)-2,5-bis(pyridine-3-carbonyloxymethyl)oxolan-3-yl] pyridine-3-carboxylate | ||
| Line 25: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
== | |||
'''Nicofuranose''' is a [[niacin]] derivative used as a [[hypolipidemic agent]]. | '''Nicofuranose''' is a [[niacin]] derivative used as a [[hypolipidemic agent]]. | ||
==References== | |||
{{reflist|2}} | |||
{{Lipid modifying agents}} | {{Lipid modifying agents}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category: | [[Category:Cardiovascular Drugs]] | ||
[[Category: | [[Category:Nicotinates]] | ||
Latest revision as of 17:11, 27 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C30H24N4O10 |
| Molar mass | 600.533 g/mol |
|
WikiDoc Resources for Nicofuranose |
|
Articles |
|---|
|
Most recent articles on Nicofuranose Most cited articles on Nicofuranose |
|
Media |
|
Powerpoint slides on Nicofuranose |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nicofuranose at Clinical Trials.gov Clinical Trials on Nicofuranose at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nicofuranose
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nicofuranose Discussion groups on Nicofuranose Patient Handouts on Nicofuranose Directions to Hospitals Treating Nicofuranose Risk calculators and risk factors for Nicofuranose
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nicofuranose |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nicofuranose is a niacin derivative used as a hypolipidemic agent.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Nicotinates